×

Consolidation on the cards for Asia's pharma space?

8:31 PM ET Mon, 26 May 2014

Emilia Falcetti, Analyst, Japan Healthcare Equity Research at Cantor Fitzgerald, discusses whether Asian pharmaceuticals will follow their global peers in "ditching the diversification model."